Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at Scleroderma (SSc) Patients Compared Healthy Peoples

Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at SSc Patients Compared Healthy Peoples

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01553890

Acronym

SSc

Enrollment

Registered

2012-03-14

Start date

2012-03-31

Completion date

2013-03-31

Last updated

2012-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleroderma

Keywords

SSc= scleroderma, ICF+ informed consent form, age 18 to 85, healthy

Brief summary

The aim is to find the presence of anti vitamin D antibodies in scleroderma patients and compare with control. A second goal is anti vitamin D levels in serum of scleroderma patients in relation to the clinical manifestations of the disease.

Detailed description

Blood samples from 30 scleroderma patients compared to 30 healthy peoples to reach the target of variation of the blood level vitamin D antibody between this groups

Interventions

OTHERBlood sample

blood sample, venous blood, about 10 ml will be drawn from participants

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

study group 1. patients with SSc 2. age - 18 years old and older 3. sign ICF control group - healthy people

Design outcomes

Primary

Measure	Time frame
Presence of anti vitamin D antibodies in scleroderma patients compared with control	March 2013 (up to one year)

Secondary

Measure	Time frame
Anti vitamin D presence and levels in serum in relation to the clinical manifestations of scleroderma	March 2013 (up to one year)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026